R Pero
Overview
Explore the profile of R Pero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wong A, Pero R, Ormonde P, Tavtigian S, Bartel P
J Biol Chem
. 1998 Jan;
272(51):31941-4.
PMID: 9405383
Recent work has shown that the murine BRCA2 tumor suppressor protein interacts with the murine RAD51 protein. This interaction suggests that BRCA2 participates in DNA repair. Residues 3196-3232 of the...
12.
Teng D, Perry 3rd W, Hogan J, Baumgard M, Bell R, Berry S, et al.
Cancer Res
. 1997 Oct;
57(19):4177-82.
PMID: 9331070
Mitogen-activated protein kinases function in signal transduction pathways that are involved in controlling key cellular processes in many organisms. A mammalian member of this kinase family, MKK4/JNKK1/SEK1, has been reported...
13.
Johnsson A, Kjellen E, Wennerberg J, Pero R
Anticancer Drugs
. 1996 Jun;
7(4):483-8.
PMID: 8826617
The antiemetic drug metoclopramide (MCA) has previously been shown to cause DNA damage, to inhibit DNA repair and to enhance the effect of the chemotherapeutic agent cisplatin. Cisplatin acts by...
14.
Wennerberg J, Kjellen E, Lybak S, RYDELL R, Pero R
Anticancer Res
. 1993 Nov;
13(6B):2501-6.
PMID: 8135490
In order to improve the treatment of advanced H&N cancer we must consider to adopt new strategies as: new/better cytostatic agents; new combinations of present cytostatic agents and; potentiation of...
15.
Mayer J, Warburton D, Jeffrey A, Pero R, Walles S, Andrews L, et al.
Mutat Res
. 1991 May;
248(1):163-76.
PMID: 2030705
Ethylene oxide (EtO) is an alkylating agent and a model direct-acting mutagen and carcinogen. This study has evaluated a panel of biologic markers including EtO-hemoglobin adducts (EtO-Hb), sister-chromatid exchanges (SCEs),...
16.
Lybak S, Kjellen E, Wennerberg J, Pero R
Int J Radiat Oncol Biol Phys
. 1990 Dec;
19(6):1419-24.
PMID: 2262366
The commonly used drug metoclopramide, a benzamide derivative, has been shown previously in our laboratory to enhance the effect of cisplatin on xenografted squamous cell carcinomas of the head and...
17.
Kjellen E, Wennerberg J, Pero R
Br J Cancer
. 1989 Feb;
59(2):247-50.
PMID: 2930689
The chromatin-bound enzyme adenosine diphosphate ribosyl transferase is activated by DNA-damaging agents. Substances that inhibit the enzyme, such as benzamide analogues, are known to increase the cytotoxicity of ionising radiation...
18.
Pero R, Hagmar L, Seidegard J, Bellander T, Attewell R, Skerfving S
Int Arch Occup Environ Health
. 1988 Jan;
60(6):445-51.
PMID: 3137175
A chemical plant, where an increased number of non-Hodgkin's lymphomas and myelomas had been observed, was monitored for genotoxic effects occurring in peripheral mononuclear leukocyte samples from 76 exposed workers....
19.
Lindholm L, Bryngelsson T, Pero R
Environ Res
. 1986 Jun;
40(1):202-9.
PMID: 3709496
The levels of N-acetoxy-2-acetylaminofluorene (NA-AAF)-induced unscheduled DNA synthesis (UDS) were determined in resting mononuclear leukocytes from males in a geographically defined population. The mutagen sensitivity, as determined by the NA-AAF...
20.
Arnason U, Pero R, LIMA-DE-FARIA A
Hereditas
. 1977 Feb;
84(2):221-4.
PMID: 838600
No abstract available.